Vildagliptin 50 mg / metformin 500 mg
Vildagliptin 50 mg / metformin 850 mg
Vildagliptin 50 mg / metformin 1000 mg
Image
Product Description
- Vildoza-Met is a combination of Vildagliptin and Metformin, indicated to improve glycemic control in adults with type 2 diabetes mellitus who are not adequately controlled by taking metformin alone.
- Suitable treatment option for broad populations with different characteristics.
- Effective in reducing HbA1c in patients who need to progress to dual therapy.
- Has better efficacy than metformin monotherapy.
- Enables patients to achieve targeted glycemic control.
- Reduces postprandial plasma glucose and fasting plasma glucose levels.
- Simple treatment regimen (single-pill combination).
- Considered as weight neutral drug.
- Well tolerated.